Literature DB >> 19138368

Testosterone therapy in women with gynecological and sexual disorders: a triumph of clinical endocrinology from 1938 to 2008.

Abdulmaged M Traish1, Robert J Feeley, Andre T Guay.   

Abstract

INTRODUCTION: Although the term "medicalization" has been used by some to describe contemporary testosterone use in women with sexual disorders and testosterone deficiency syndrome, testosterone therapy for women with various gynecological and sexual disorders has been practiced since the late 1930s. AIM: The study aimed to perform a historical review of testosterone use in women with sexual and gynecological disorders. This review is necessary to bridge important knowledge gaps in the clinical use of testosterone in women with sexual health concerns and to provoke new thoughts and understanding of the multidisciplinary role of testosterone in women's overall health.
METHODS: Review of medical literature on androgen therapy in women was carried out from 1938 through 2008.
RESULTS: Approximately 70 years ago, clinicians from various disciplines relied on personal experience and clinical observations for outcome assessment of testosterone therapy in women. These early reports on testosterone use in women with sexual medical problems served as a foundation for the development of contemporary approaches and subsequent testosterone treatment regimens. Testosterone use was reported for sexual dysfunction, abnormal uterine bleeding, dysmenorrhea, menopausal symptoms, chronic mastitis and lactation, and benign and malignant tumors of the breast, uterus, and ovaries.
CONCLUSIONS: Health-care professionals engaged in the management of women's health issues have observed the benefits of androgen therapy throughout much of the 20th century. Despite this clinical use of testosterone in women for more than seven decades, contemporary testosterone therapy in women is hotly debated, misunderstood, and often misrepresented in the medical community.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19138368     DOI: 10.1111/j.1743-6109.2008.01121.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

1.  Breast Cancer Incidence Reduction in Women Treated with Subcutaneous Testosterone: Testosterone Therapy and Breast Cancer Incidence Study.

Authors:  Gary Donovitz; Mandy Cotten
Journal:  Eur J Breast Health       Date:  2021-03-31

2.  Importance of revealing a rare case of breast cancer in a female to male transsexual after bilateral mastectomy.

Authors:  Dejan V Nikolic; Miroslav L Djordjevic; Miroslav Granic; Aleksandra T Nikolic; Violeta V Stanimirovic; Darko Zdravkovic; Svetlana Jelic
Journal:  World J Surg Oncol       Date:  2012-12-28       Impact factor: 2.754

Review 3.  Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.

Authors:  Sandra Léa Bonfim Reis; Carmita H N Abdo
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

4.  Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy.

Authors:  Melissa Dahir; Dianne Travers-Gustafson
Journal:  Sex Med       Date:  2014-04       Impact factor: 2.491

5.  Modeling Human Sexual Motivation in Rodents: Some Caveats.

Authors:  Olivia Le Moëne; Anders Ågmo
Journal:  Front Behav Neurosci       Date:  2019-08-27       Impact factor: 3.558

6.  Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study.

Authors:  Rebecca L Glaser; Anne E York; Constantine Dimitrakakis
Journal:  BMC Cancer       Date:  2019-12-30       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.